Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLUNASDAQ:PCT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUBELLUS Health$14.74$14.62$6.38▼$14.76$1.87B0.193.08 million shs3.45 million shsPCTPureCycle Technologies$11.67+4.2%$7.83$4.50▼$15.58$2.10B1.82.52 million shs3.02 million shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUBELLUS Health0.00%0.00%0.00%0.00%0.00%PCTPureCycle Technologies+1.73%+12.79%+37.76%+54.91%+89.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUBELLUS HealthN/AN/AN/AN/AN/AN/AN/AN/APCTPureCycle Technologies1.3005 of 5 stars1.41.00.00.04.13.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUBELLUS Health 0.00N/AN/AN/APCTPureCycle Technologies 2.75Moderate Buy$12.002.83% UpsideCurrent Analyst Ratings BreakdownLatest BLU, PCT, ATST, and ABDN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025PCTPureCycle TechnologiesTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy$15.00 ➝ $13.00(Data available from 6/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUBELLUS Health$15K124,613.93N/AN/A$3.09 per share4.77PCTPureCycle Technologies$1.58M1,326.24N/AN/A$2.56 per share4.56Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUBELLUS Health-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/APCTPureCycle Technologies-$101.71M-$1.17N/AN/AN/AN/A-52.63%-20.69%8/6/2025 (Estimated)Latest BLU, PCT, ATST, and ABDN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025PCTPureCycle Technologies-$0.25-$0.27-$0.02$0.05$4.27 million$1.58 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUBELLUS HealthN/AN/AN/AN/AN/APCTPureCycle TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUBELLUS HealthN/A33.4233.42PCTPureCycle Technologies1.361.741.63Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUBELLUS Health90.37%PCTPureCycle Technologies63.01%Insider OwnershipCompanyInsider OwnershipBLUBELLUS Health24.17%PCTPureCycle Technologies21.67%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLUBELLUS Health74126.81 million96.16 millionNot OptionablePCTPureCycle Technologies120179.56 million153.71 millionNot OptionableBLU, PCT, ATST, and ABDN HeadlinesRecent News About These CompaniesFY2026 Earnings Estimate for PCT Issued By Cantor FitzgeraldJune 11 at 8:45 AM | marketbeat.comPureCycle Technologies (NASDAQ:PCT) Stock Price Up 8.1% - Time to Buy?June 9 at 3:31 PM | marketbeat.comApella Capital LLC Takes $286,000 Position in PureCycle Technologies, Inc. (NASDAQ:PCT)June 6, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in PureCycle Technologies, Inc. (NASDAQ:PCT)June 6, 2025 | marketbeat.comPureCycle Technologies (NASDAQ:PCT) Stock Price Down 5.1% - Here's WhyMay 30, 2025 | marketbeat.com50,166 Shares in PureCycle Technologies, Inc. (NASDAQ:PCT) Purchased by Copia Wealth ManagementMay 29, 2025 | marketbeat.comForum Financial Management LP Cuts Stake in PureCycle Technologies, Inc. (NASDAQ:PCT)May 29, 2025 | marketbeat.comPolar Asset Management Partners Inc. Makes New $3.29 Million Investment in PureCycle Technologies, Inc. (NASDAQ:PCT)May 28, 2025 | marketbeat.comPureCycle Technologies, Inc. (NASDAQ:PCT) Stock Holdings Lifted by Deutsche Bank AGMay 27, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Decreases Position in PureCycle Technologies, Inc. (NASDAQ:PCT)May 26, 2025 | marketbeat.comHighview Capital Management LLC DE Takes $324,000 Position in PureCycle Technologies, Inc. (NASDAQ:PCT)May 24, 2025 | marketbeat.comNorthern Trust Corp Raises Position in PureCycle Technologies, Inc. (NASDAQ:PCT)May 19, 2025 | marketbeat.com321,000 Shares in PureCycle Technologies, Inc. (NASDAQ:PCT) Acquired by Polar Asset Management Partners Inc.May 18, 2025 | marketbeat.comLighthouse Investment Partners LLC Invests $410,000 in PureCycle Technologies, Inc. (NASDAQ:PCT)May 17, 2025 | marketbeat.comFY2025 Earnings Forecast for PCT Issued By Cantor FitzgeraldMay 13, 2025 | marketbeat.comPureCycle Achieves New Milestone in Recycled Plastic Film TrialsMay 13, 2025 | packworld.comCan PureCycle Technologies (PCT) Climb 67.35% to Reach the Level Wall Street Analysts Expect?May 12, 2025 | zacks.comEarnings call transcript: Purecycle Technologies Q1 2025 sees stock rise post-callMay 9, 2025 | investing.comPureCycle Technologies, Inc. (PCT) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comPureCycle Technologies, Inc. (PCT) Reports Q1 Loss, Lags Revenue EstimatesMay 7, 2025 | zacks.comPureCycle Technologies First Quarter 2025 Corporate UpdateMay 7, 2025 | accessnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in Value3 Top Dividend Stocks Analysts Are Bullish on Right NowBy Chris Markoch | June 6, 2025View 3 Top Dividend Stocks Analysts Are Bullish on Right NowDon’t Take Dick’s Sporting Goods Seriously? Big MistakeBy Thomas Hughes | May 29, 2025View Don’t Take Dick’s Sporting Goods Seriously? Big Mistake3 Tech Focused ETFs to Watch as the Market Nears All-Time HighsBy Ryan Hasson | June 11, 2025View 3 Tech Focused ETFs to Watch as the Market Nears All-Time HighsBLU, PCT, ATST, and ABDN Company DescriptionsBELLUS Health NASDAQ:BLUBELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.PureCycle Technologies NASDAQ:PCT$11.67 +0.47 (+4.20%) As of 04:00 PM EasternPureCycle Technologies, Inc. engages in the production of recycled polypropylene (PP). The company holds a license for restoring waste PP into ultra-pure recycled polypropylene resin that has multiple applications, including packaging and labeling for consumer products, piping, ropes, cabling, and plastic parts for various industries. Its recycling process separates color, odor, and other contaminants from plastic waste feedstock to transform it into virgin-like resin. The company was founded in 2015 and is headquartered in Orlando, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ignore the Noise—Samsara Stock Is Still a Strong Buy Oracle’s Cloud Boom Is Just Getting Started Netflix Sets New Highs—Price Targets Keep Climbing IonQ’s $1B Acquisition and Drug Discovery Leap With NVIDIA Alibaba’s Dip Is a Gift—Here’s the Price That Matters Betting on Disruption: Is Lemonade the Future of Insurance? Starbucks Stock: Culture Fix May Be Key to Long-Term Growth GameStop Turns a Profit, But Core Business Keeps Shrinking Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
